X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (55132) 55132
Book Review (9077) 9077
Newsletter (6740) 6740
Publication (4110) 4110
Conference Proceeding (568) 568
Book Chapter (256) 256
Dissertation (245) 245
Magazine Article (174) 174
Newspaper Article (123) 123
Book / eBook (51) 51
Web Resource (47) 47
Trade Publication Article (20) 20
Journal / eJournal (14) 14
Reference (14) 14
Paper (12) 12
Government Document (8) 8
Data Set (3) 3
Presentation (3) 3
Streaming Video (2) 2
Transcript (2) 2
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (40496) 40496
humans (36605) 36605
helicobacter pylori (36392) 36392
male (18633) 18633
female (18209) 18209
middle aged (14336) 14336
gastroenterology & hepatology (13469) 13469
adult (12969) 12969
infection (12222) 12222
helicobacter infections (10364) 10364
aged (10312) 10312
helicobacter infections - drug therapy (8612) 8612
helicobacter infections - complications (8255) 8255
research (7534) 7534
helicobacter infections - microbiology (7404) 7404
helicobacter pylori - isolation & purification (7097) 7097
helicobacter-pylori (6960) 6960
microbiology (6625) 6625
helicobacter-pylori infection (6576) 6576
animals (6517) 6517
risk factors (6154) 6154
cancer (5924) 5924
health aspects (5877) 5877
helicobacter infections - diagnosis (5546) 5546
prevalence (5212) 5212
stomach cancer (4927) 4927
adolescent (4738) 4738
gastritis (4695) 4695
abridged index medicus (4688) 4688
eradication (4658) 4658
helicobacter infections - epidemiology (4594) 4594
helicobacter pylori - drug effects (4118) 4118
helicobacter pylori - immunology (4049) 4049
gastritis - microbiology (3984) 3984
oncology (3941) 3941
helicobacter infections - pathology (3895) 3895
aged, 80 and over (3799) 3799
gastric cancer (3770) 3770
helicobacter pylori - pathogenicity (3731) 3731
helicobacter pylori - genetics (3703) 3703
anti-bacterial agents - therapeutic use (3616) 3616
analysis (3543) 3543
gastric mucosa - pathology (3516) 3516
child (3322) 3322
drug therapy, combination (3295) 3295
gastric mucosa - microbiology (3275) 3275
disease (3248) 3248
immunology (3158) 3158
medical research (3101) 3101
infections (3062) 3062
biopsy (3044) 3044
pharmacology & pharmacy (3037) 3037
diagnosis (3034) 3034
stomach neoplasms - microbiology (3015) 3015
risk (2956) 2956
medicine, general & internal (2917) 2917
mice (2894) 2894
treatment outcome (2827) 2827
helicobacter infections - immunology (2812) 2812
bacteria (2776) 2776
infectious diseases (2761) 2761
stomach (2747) 2747
epidemiology (2720) 2720
stomach neoplasms - pathology (2702) 2702
medicine, experimental (2651) 2651
inflammation (2647) 2647
prospective studies (2581) 2581
expression (2560) 2560
duodenal-ulcer (2476) 2476
care and treatment (2468) 2468
genetic aspects (2357) 2357
children (2297) 2297
anti-ulcer agents - therapeutic use (2272) 2272
bacterial proteins - genetics (2228) 2228
peptic ulcer (2168) 2168
gastritis - pathology (2129) 2129
campylobacter-pylori (2094) 2094
case-control studies (2073) 2073
polymerase chain reaction (2055) 2055
medicine & public health (1996) 1996
association (1983) 1983
gastroenterology (1971) 1971
peptic ulcer - microbiology (1959) 1959
carcinoma (1952) 1952
endoscopy (1942) 1942
ulcers (1905) 1905
gastrointestinal diseases (1904) 1904
biochemistry & molecular biology (1860) 1860
pathology (1834) 1834
child, preschool (1833) 1833
clarithromycin (1826) 1826
therapy (1820) 1820
young adult (1820) 1820
proton pump inhibitors (1819) 1819
sensitivity and specificity (1818) 1818
helicobacter infections - metabolism (1808) 1808
omeprazole (1805) 1805
population (1769) 1769
antibodies, bacterial - blood (1759) 1759
chronic disease (1758) 1758
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (34) 34
Online Resources - Online (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (56329) 56329
Japanese (1099) 1099
Spanish (857) 857
German (746) 746
Korean (732) 732
Russian (697) 697
French (692) 692
Chinese (556) 556
Polish (286) 286
Portuguese (164) 164
Italian (115) 115
Turkish (94) 94
Czech (69) 69
Hungarian (68) 68
Swedish (64) 64
Persian (53) 53
Danish (52) 52
Croatian (41) 41
Ukrainian (36) 36
Dutch (35) 35
Norwegian (22) 22
Serbian (21) 21
Romanian (19) 19
Finnish (15) 15
Hebrew (13) 13
Slovak (12) 12
Slovenian (9) 9
Lithuanian (6) 6
Bulgarian (5) 5
Bosnian (4) 4
Icelandic (3) 3
Arabic (2) 2
Indonesian (1) 1
Latin (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 17, pp. 1597 - 1604
Journal Article
2002, Infectious agents and pathogenesis., ISBN 9780306466588, xxviii, 286
Book
Gut, ISSN 0017-5749, 01/2017, Volume 66, Issue 1, pp. 6 - 30
Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects... 
CONTAINING QUADRUPLE THERAPY | STANDARD TRIPLE THERAPY | RANDOMIZED-CONTROLLED-TRIALS | C-13-UREA BREATH TEST | LOW-DOSE ASPIRIN | GASTROESOPHAGEAL-REFLUX DISEASE | PROTON-PUMP INHIBITOR | GASTRIC-CANCER RISK | DUODENAL-ULCER PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | 3RD-LINE RESCUE THERAPY | Humans | Helicobacter Infections - prevention & control | Drug Resistance, Bacterial | Helicobacter Infections - complications | Bismuth - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Nitroimidazoles - therapeutic use | Helicobacter pylori | Helicobacter Infections - drug therapy | Gastritis - microbiology | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Stomach Neoplasms - diagnosis | Early Detection of Cancer | Risk Factors | Gastrointestinal Microbiome | Fluoroquinolones - therapeutic use | Clarithromycin - therapeutic use | Dyspepsia - microbiology | Gastroscopy | Evidence-Based Medicine | Proton Pump Inhibitors - therapeutic use | Stomach Neoplasms - microbiology | Amoxicillin - therapeutic use | Stomach - microbiology | Practice Guidelines as Topic | Helicobacter infections | Care and treatment | Wellness programs | Usage | Working groups | Systematic review | Staphylococcus infections | Management | Stomach cancer | Delphi method | Meta-analysis | Probiotics | Microbiota | Infectious diseases | Antibiotics | Ulcers | Patient satisfaction | Public health | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Gastroenterology and Hepatology (Australia), ISSN 0815-9319, 2009, Volume 24, Issue 10, pp. 1587 - 1600
The Asia-Pacific Consensus Conference was convened to review and synthesize the most current information on Helicobacter pylori management so as to update the... 
Helicobacter pylori:treatment and antimicrobial resistance | H. pylori and gastric cancer | Helicobacter pylori:diagnosis | C-13-UREA BREATH TEST | helicobacter pylori:diagnosis | helicobacter pylori:treatment and antimicrobial resistance | RIFABUTIN TRIPLE THERAPY | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | GASTROESOPHAGEAL-REFLUX DISEASE | VS. QUADRUPLE THERAPY | 2ND-LINE TREATMENT | ERADICATION THERAPY | DUODENAL-ULCER PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | PEPTIC-ULCER | Predictive Value of Tests | Helicobacter Infections - ethnology | Humans | Breath Tests | Drug Resistance, Bacterial | Helicobacter Infections - complications | Treatment Outcome | Evidence-Based Medicine | Proton Pump Inhibitors - therapeutic use | Helicobacter Infections - therapy | Anti-Bacterial Agents - therapeutic use | Asia - epidemiology | Asian Continental Ancestry Group | Helicobacter pylori - isolation & purification | Microbiological Techniques | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Helicobacter Infections - microbiology | Gastroesophageal reflux | Medical colleges | Drug resistance in microorganisms | Aspirin | Care and treatment | Anemia | Antidiarrheals | Cytochrome P-450 | Practice guidelines (Medicine) | Peptic ulcer | Antiulcer drugs | Prevention | Helicobacter pylori | Amoxicillin | Lymphomas | Health aspects | Smoking | Cancer | Index Medicus
Journal Article
04/2013
Background: Helicobacter pylori-infection associated gastritis is known to be a significant risk factor of gastric cancer. Serum levels of Gastrin-17 and... 
Helicobacter pylori | atrophic gastritis | pepsinogen | gastrin
Web Resource
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 08/2019, Volume 34, Issue 8, pp. 1337 - 1343
Several strategies have been proposed to increase the eradication rate of Helicobacter pylori. However, the widespread increasing resistance rates to current... 
Helicobacter pylori | endoscopy | disease eradication | Antigens | Urea | Drug resistance in microorganisms | Care and treatment | Helicobacter infections | Endoscopy | Health aspects | Pathogens | Pain | Antibiotics | Mucosa | Clinical trials | Patients | Index Medicus
Journal Article
BioMed Research International, ISSN 2314-6133, 2015, Volume 2015, pp. 278308 - 278308
  Several strategies including sequential, concomitant, and hybrid therapies are therefore proposed to increase the eradication rate of first-line treatment... 
MEDICINE, RESEARCH & EXPERIMENTAL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Helicobacter Infections - pathology | Humans | Helicobacter pylori - pathogenicity | Helicobacter Infections - microbiology | Health care | Hospitals | Antibiotics | Internal medicine | Ulcers | Colleges & universities | Gastroenterology | Infections | Stomach cancer | Index Medicus
Journal Article
Journal Article
Gut, ISSN 0017-5749, 05/2013, Volume 62, Issue 5, pp. 676 - 682
Objective To evaluate the benefit of mass eradication of Helicobacter pylori infection in reducing premalignant gastric lesions. Design Mass eradication of H... 
COST-EFFECTIVENESS ANALYSIS | DESIGN | TAIWAN | ENDOSCOPIC RESECTION | MARKOV MODEL | RISK | CLASSIFICATION | THERAPIES | RANDOMIZED CONTROLLED-TRIAL | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | Metaplasia - microbiology | Recurrence | Prevalence | Follow-Up Studies | Humans | Middle Aged | Peptic Ulcer - prevention & control | Helicobacter pylori - drug effects | Male | Multiphasic Screening | Incidence | Anti-Bacterial Agents - therapeutic use | Peptic Ulcer - microbiology | Helicobacter Infections - drug therapy | Adult | Female | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Odds Ratio | Anti-Ulcer Agents - therapeutic use | Risk Factors | Breath Tests | Helicobacter Infections - epidemiology | Treatment Outcome | Clarithromycin - therapeutic use | Stomach Neoplasms - microbiology | Algorithms | Stomach Neoplasms - prevention & control | Taiwan - epidemiology | Metaplasia - prevention & control | Precancerous Conditions - microbiology | Precancerous Conditions - prevention & control | Prevention | Helicobacter infections | Research | Stomach cancer | Disease prevention | Studies | Surveillance | Disease | Ulcers | Mortality | Sanitation | Infections | Endoscopy | Index Medicus | Abridged Index Medicus | molecular oncology | colonic neoplasms | colorectal adenomas | cancer prevention | gastric lymphoma | helicobacter pylori - pathogenesis | cancer registries | oesophageal cancer | colonic polyps | chemoprevention | Helicobacter Pylori | colorectal cancer screening | endoscopic polypectomy | colonoscopy | colorectal neoplasia | gastric cancer | meta-analysis | endoscopy | gastro-oesophageal reflux disease | endoscopic procedures | colorectal neoplasm | cancer epidemiology | 1506 | gastrointestinal neoplasia | statistics
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 01/2019, Volume 34, Issue 1, pp. 120 - 123
Journal Article